Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group

Ater Joann L.; Xia Caihong; Mazewski Claire M.; Booth Timothy N.; Freyer David R.; Packer Roger J.; Sposto Richard; Vezina Gilbert; Pollack Ian F.

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group

【24h】

Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group

机译：接受卡铂和长春新碱治疗进展性低度神经胶质瘤的1型神经纤维瘤病和1型非神经纤维瘤病儿童的非随机比较：儿童肿瘤小组的报告

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDTo evaluate tumor responses, event-free survival (EFS), overall survival (OS), and toxicity of chemotherapy, children with neurofibromatosis type 1 (NF1) and progressive low-grade glioma were enrolled into the Children's Oncology Group (COG) A9952 protocol and treated with carboplatin and vincristine (CV).

机译：背景为了评估肿瘤反应，无事件生存期（EFS），总生存期（OS）和化学疗法的毒性，将1型神经纤维瘤病（NF1）和进行性低度神经胶质瘤患儿纳入儿童肿瘤学组（COG）A9952方案并用卡铂和长春新碱（CV）治疗。

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2016年第12期|共9页
作者
Ater Joann L.; Xia Caihong; Mazewski Claire M.; Booth Timothy N.; Freyer David R.; Packer Roger J.; Sposto Richard; Vezina Gilbert; Pollack Ian F.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
carboplatin; childhood low-grade glioma; neurofibromatosis 1; pilocytic astrocytoma; vincristine;

机译：卡铂;儿童低度神经胶质瘤;神经纤维瘤病1;多发性星形细胞瘤;长春新碱;

相似文献

外文文献
中文文献
专利

1. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group [J] . Ater Joann L., Xia Caihong, Mazewski Claire M., Cancer: A Journal of the American Cancer Society . 2016,第12期

机译：接受卡铂和长春新碱治疗进展性低度神经胶质瘤的1型神经纤维瘤病和1型非神经纤维瘤病儿童的非随机比较：儿童肿瘤小组的报告
2. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study [J] . Chintagumpala Murali, Eckel Sandrah P., Krailo Mark, Neuro-Oncology . 2015,第8期

机译：使用卡铂，长春新碱和替莫唑胺治疗进行性/有症状的低度神经胶质瘤儿童的试验研究：儿童肿瘤小组研究
3. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial United Kingdom (UK) cohort [J] . Kevin M. Falzon, Evangelos Drimtzias, Susan Picton, Journal of AAPOS: The official publication of the American Association for Pediatric Ophthalmology and Strabismus . 2018,第4期

机译：视觉结果在有没有神经纤维瘤病的儿童中的化疗后化疗1型：2型儿科肿瘤学会的结果（SIOP）低级神经胶质瘤2004审判英国（英国）队列
4. Describing the attention deficit profile of children with neurofibromatosis type 1 using a virtual classroom environment [C] . Gilboa Yafit, Rosenblum Sara, Fattal-Valevski Aviva, 2011 International Conference on Virtual Rehabilitation . 2011

机译：使用虚拟教室环境描述1型神经纤维瘤病儿童的注意力缺陷状况
5. Early indicators of academic difficulties in children with neurofibromatosis type 1. [D] . Janke, Kelly M. 2013

机译：1型神经纤维瘤病儿童学业困难的早期指标
6. Non-randomized Comparison between Neurofibromatosis Type 1 (NF1) and Non-NF1 Children Who Received Carboplatin and Vincristine (CV) for Progressive Low Grade Glioma (LGG): a Report from the Children’s Oncology Group (COG) [O] . Joann L. Ater, Caihong Xia, Claire M. Mazewski, -1

机译：进行卡铂和长春新碱（CV）进行性低度胶质瘤（LGG）接受治疗的1型神经纤维瘤病（NF1）和非NF1儿童的非随机比较：儿童肿瘤学组（COG）的一份报告
7. A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study [O] . R. I. Jakacki, E. Bouffet, P. C. Adamson, 2011

机译：与低级胶质瘤儿童组合的调控素相结合的第1阶段研究：儿童肿瘤学阶段第1期联盟研究

Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group

摘要

著录项

相似文献

相关主题

期刊订阅